||
FOXA2在调控前列腺腺癌向神经内分泌癌谱系转变和KIT信号通路活化过程中的关键作用,发现KIT抑制剂具有治疗神经内分泌前列腺癌的临床应用前景。https://www.ebiotrade.com/newsf/2022-11/2022118105137215.htm
相关研究 主题词 可参考
http://www.pubmedplus.cn/P/SearchQuickResult?wd=eb65c4a4-23ec-4dfc-8988-61afbf73018f
01. | 2022 | 1 篇 | 4.167% |
02. | 2021 | 3 篇 | 12.500% |
03. | 2020 | 1 篇 | 4.167% |
04. | 2018 | 1 篇 | 4.167% |
05. | 2017 | 2 篇 | 8.333% |
06. | 2014 | 1 篇 | 4.167% |
07. | 2013 | 2 篇 | 8.333% |
08. | 2011 | 1 篇 | 4.167% |
09. | 2010 | 4 篇 | 16.667% |
10. | 2009 | 1 篇 | 4.167% |
01. | prostate | 4 篇 | 16.667% |
02. | cancer res | 2 篇 | 8.333% |
03. | am j clin exp urol | 1 篇 | 4.167% |
04. | am j pathol | 1 篇 | 4.167% |
05. | ann n y acad sci | 1 篇 | 4.167% |
06. | cancer cell | 1 篇 | 4.167% |
07. | cancer sci | 1 篇 | 4.167% |
08. | endocr relat cancer | 1 篇 | 4.167% |
09. | int j oncol | 1 篇 | 4.167% |
10. | iscience | 1 篇 | 4.167% |
01. | 美国 | 20 篇 | 83.333% |
02. | 中国 | 4 篇 | 16.667% |
03. | 加拿大 | 3 篇 | 12.500% |
04. | 日本 | 2 篇 | 8.333% |
05. | 韩国 | 1 篇 | 4.167% |
06. | 瑞士 | 1 篇 | 4.167% |
07. | 以色列 | 1 篇 | 4.167% |
08. | 意大利 | 1 篇 | 4.167% |
09. | 英国 | 1 篇 | 4.167% |
01. | 中国上海 | 1 篇 | 4.167% |
02. | 中国杭州 | 1 篇 | 4.167% |
03. | 中国厦门 | 1 篇 | 4.167% |
04. | 中国郑州 | 1 篇 | 4.167% |
05. | 中国武汉 | 1 篇 | 4.167% |
06. | 中国重庆 | 1 篇 | 4.167% |
07. | 中国香港 | 1 篇 | 4.167% |
01. | Male | 21 篇 | 87.500% |
02. | Prostatic Neoplasms | 21 篇 | 87.500% |
03. | Animals | 19 篇 | 79.167% |
04. | Humans | 16 篇 | 66.667% |
05. | Mice | 14 篇 | 58.333% |
06. | Hepatocyte Nuclear Factor 3-beta | 13 篇 | 54.167% |
07. | Gene Expression Regulation, Neoplastic | 12 篇 | 50.000% |
08. | Adenocarcinoma | 10 篇 | 41.667% |
09. | Cell Line, Tumor | 9 篇 | 37.500% |
10. | Mice, Transgenic | 9 篇 | 37.500% |
Archiver|手机版|科学网 ( 京ICP备07017567号-12 )
GMT+8, 2024-5-24 19:22
Powered by ScienceNet.cn
Copyright © 2007- 中国科学报社